Evogene (EVGN) — Net Asset Quality Index
Evogene (EVGN) has a Net Asset Quality Index of 66.1% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ILA26.09 Million minus total liabilities of ILA8.83 Million yields net assets of ILA17.25 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Evogene (EVGN) asset resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Evogene Net Asset Quality Index Over Time (2006–2024)
This chart shows how Evogene's Net Asset Quality Index has evolved across 19 annual periods from 2006 to 2024. As of September 2025, the index stands at 66.1%, representing net assets of ILA17.25 Million against total assets of ILA26.09 Million ILA. See EVGN net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Evogene (2006–2024)
The table below presents the year-by-year Net Asset Quality Index for Evogene from 2006 to 2024, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Evogene stock valuation.
| Year | Quality Index | Net Assets (ILA) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 37.2% | ILA14.84 Million | ILA39.86 Million | ILA25.03 Million | ▼ -18.9 pp |
| 2023 | 56.1% | ILA28.68 Million | ILA51.10 Million | ILA22.42 Million | ▼ -5.9 pp |
| 2022 | 62.0% | ILA34.79 Million | ILA56.13 Million | ILA21.34 Million | ▼ -21.1 pp |
| 2021 | 83.1% | ILA63.42 Million | ILA76.30 Million | ILA12.88 Million | ▲ +4.0 pp |
| 2020 | 79.1% | ILA56.88 Million | ILA71.92 Million | ILA15.03 Million | ▼ -5.3 pp |
| 2019 | 84.4% | ILA60.22 Million | ILA71.36 Million | ILA11.15 Million | ▼ -1.3 pp |
| 2018 | 85.7% | ILA50.31 Million | ILA58.69 Million | ILA8.39 Million | ▼ -3.7 pp |
| 2017 | 89.4% | ILA69.38 Million | ILA77.60 Million | ILA8.22 Million | ▼ -1.5 pp |
| 2016 | 90.9% | ILA87.29 Million | ILA95.99 Million | ILA8.70 Million | ▼ -1.2 pp |
| 2015 | 92.1% | ILA103.75 Million | ILA112.59 Million | ILA8.84 Million | ▲ +1.2 pp |
| 2014 | 91.0% | ILA116.08 Million | ILA127.59 Million | ILA11.50 Million | ▲ +0.1 pp |
| 2013 | 90.8% | ILA124.75 Million | ILA137.31 Million | ILA12.56 Million | ▲ +16.4 pp |
| 2012 | 74.4% | ILA48.26 Million | ILA64.86 Million | ILA16.60 Million | ▲ +3.6 pp |
| 2011 | 70.8% | ILA48.09 Million | ILA67.89 Million | ILA19.80 Million | ▲ +31.8 pp |
| 2010 | 39.0% | ILA16.73 Million | ILA42.87 Million | ILA26.14 Million | ▼ -6.1 pp |
| 2009 | 45.1% | ILA19.34 Million | ILA42.88 Million | ILA23.54 Million | ▲ +16.8 pp |
| 2008 | 28.3% | ILA9.61 Million | ILA33.95 Million | ILA24.34 Million | ▼ -25.2 pp |
| 2007 | 53.5% | ILA5.71 Million | ILA10.67 Million | ILA4.96 Million | ▼ -30.3 pp |
| 2006 | 83.8% | ILA16.36 Million | ILA19.52 Million | ILA3.16 Million | — |